Ropes Wealth Advisors’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-601
Closed -$3.58K 274
2022
Q4
$3.58K Sell
601
-1
-0.2% -$6 ﹤0.01% 268
2022
Q3
$4K Hold
602
﹤0.01% 254
2022
Q2
$5K Hold
602
﹤0.01% 266
2022
Q1
$5K Hold
602
﹤0.01% 288
2021
Q4
$6K Hold
602
﹤0.01% 269
2021
Q3
$11K Hold
602
﹤0.01% 275
2021
Q2
$12K Hold
602
﹤0.01% 267
2021
Q1
$11K Sell
602
-32
-5% -$2.4K ﹤0.01% 245
2020
Q4
$40K Buy
+634
New +$36.4K 0.01% 413
2019
Q1
Sell
-736
Closed -$35K 539
2018
Q4
$35K Hold
736
0.01% 335
2018
Q3
$111K Hold
736
0.03% 271
2018
Q2
$132K Hold
736
0.04% 258
2018
Q1
$184K Buy
+736
New +$202K 0.05% 225

Other funds holding ACGN

Ropes Wealth Advisors's ACGN Position: Q1 2023 in Review

Ropes Wealth Advisors sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 601 shares — an estimated $3.58K sold.

Ropes Wealth Advisors first reported a position in ACGN in Q1 2018 and held it in 13 quarters. The position peaked at $184K in Q1 2018. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.

  • Ropes Wealth Advisors reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
  • Ropes Wealth Advisors sold 601 Aceragen Inc shares in Q1 2023, an estimated $3.58K.
  • Ropes Wealth Advisors first reported a position in Aceragen Inc in Q1 2018 and held it in 13 quarters.
  • Ropes Wealth Advisors's Aceragen Inc position peaked at $184K in Q1 2018.
  • 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.

Based on Ropes Wealth Advisors's 13F filing for Q1 2023, filed 8 May 2023.